TEVA
Teva Pharmaceutical Industries Limited
NYSE
People also watch:MYLNVSAMGNGILDABT
54.730.10 (0.18%)

After hours: 54.790.06 (0.11%) as of 4:23 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close54.63
Open54.77
Bid54.63 x 100
Ask54.79 x 100
52wk Range48.01 - 72.31
Day's Range54.34 - 54.96
Volume3,479,751
Avg Vol (3m)6,303,419
As of 4:02 PM EDT. Market closed.
  • Reuters2 days ago

    Investors scrap for Teva Pharmaceutical bonds

    Teva Pharmaceutical raised more than US$20bn across three currencies this week via an acquisition-driven bond that took advantage of pent-up demand for corporate paper in a yield-starved market. Investors had been making space for the well-telegraphed deal ever since Teva announced its US$40.5bn acquisition of Allergan Generics earlier in the year, while declining rates across the developed world and a lack of recent supply in the US and European markets added impetus to the transaction. In Europe, Teva issued bonds that priced up to 35bp inside its secondary curve - and those outstanding bonds, in turn, tightened by an incredible 40bp during the execution process.

  • Bloomberg4 days ago

    Teva Gets Funding to Close Allergan Deal With Franc Bond Sale

    Teva Pharmaceutical Industries Ltd. sold Swiss-franc denominated bonds and said it had raised enough money in a sweep of markets worldwide to close a $40.5 billion acquisition.